This study is looking to enroll patients who are at a high risk of developing pancreatic cancer to see if taking an aspirin daily for one year can prevent or reduce the risk of developing cancer.
Patients with family members diagnosed with pancreatic cancer, certain genetic mutations or pancreatic abnormalities, like cysts, can be at a higher risk of developing pancreatic cancer. This study will compare patients taking aspirin to those that are not to see if it reduces the risk of changes in the pancreas. Patients will take aspirin for 1 year and then be followed for 4 years. Follow up visits would include blood draws and imaging tests if recommended by the study doctor.
What we're hoping for
We are hoping that taking a daily aspirin could help reduce the risk of pancreatic cancer in patients that are at high risk.
ClinicalTrials.gov Identifier: Not Available